No, Effexor (venlafaxine) does NOT delay ejaculation more than Prozac (fluoxetine)
Based on the highest quality evidence, venlafaxine is actually ineffective for delaying ejaculation and should not be used for premature ejaculation, while fluoxetine is an established first-line treatment with proven efficacy.
Evidence Against Venlafaxine for Ejaculatory Delay
The most recent AUA/SMSNA guidelines (2022) specifically recommend daily SSRIs as first-line pharmacotherapy for premature ejaculation, with no mention of SNRIs like venlafaxine as effective options 1. The guidelines explicitly state that paroxetine exerts the strongest ejaculation delay (8.8-fold increase in ejaculatory latency time), followed by other SSRIs including fluoxetine 1.
Direct Clinical Trial Evidence
Two randomized, placebo-controlled trials directly evaluated venlafaxine for premature ejaculation and found it no better than placebo:
- A 12-week study of venlafaxine 75 mg showed only 1.7-fold increase in ejaculatory latency versus 1.6-fold for placebo (p=0.1), with no significant difference between groups 2
- A crossover study of venlafaxine XR 75 mg for 2 weeks showed increased ejaculation time from 60 to 178 seconds, but this was statistically indifferent from placebo (126 seconds, p=0.144) 3
Both studies concluded venlafaxine has only a placebo effect on ejaculation latency and is not appropriate for treating premature ejaculation 2, 3.
Evidence Supporting Fluoxetine
In contrast, fluoxetine has robust evidence for ejaculatory delay:
- The 2004 AUA guidelines recommend fluoxetine 5-20 mg/day as effective for delaying ejaculation 4
- A landmark double-blind RCT comparing SSRIs found fluoxetine significantly delayed ejaculation to approximately 110 seconds versus 20 seconds for placebo (p<0.001) 5
- Meta-analyses confirm fluoxetine 20-40 mg daily is effective in delaying ejaculation 1
Comparative Efficacy Among SSRIs
When SSRIs were directly compared, paroxetine showed the strongest ejaculation delay, followed by fluoxetine and sertraline 5. Fluoxetine demonstrated consistent efficacy across multiple trials, while venlafaxine failed to show benefit 2, 3, 5.
Mechanism Does Not Predict Clinical Efficacy
While venlafaxine inhibits both serotonin and norepinephrine reuptake 6, this dual mechanism does not translate to superior ejaculatory delay. The FDA label for Effexor lists "abnormal ejaculation" as an adverse event 6, but clinical trials demonstrate this occurs at rates no different from placebo when treating premature ejaculation specifically 2, 3.
The serotonergic mechanism alone (as with SSRIs) appears sufficient and superior for therapeutic ejaculatory delay 1, 5.
Clinical Recommendations
- First-line options: Daily paroxetine (10-40 mg), fluoxetine (20-40 mg), or sertraline (50-200 mg) 1
- Paroxetine is most effective with 8.8-fold increase in ejaculatory latency 1
- Venlafaxine should not be used for premature ejaculation given lack of efficacy versus placebo 2, 3
Important Caveats
- Sexual dysfunction rates vary among antidepressants: paroxetine has highest rates of sexual dysfunction overall 7, 8, but this is the desired therapeutic effect for premature ejaculation
- SNRIs like venlafaxine may have higher rates of erectile dysfunction compared to SSRIs 9, which could be counterproductive
- All SSRIs should be avoided in men with bipolar depression due to mania risk 1